4,4,7,7‐Tetramethyl‐2‐tosyl‐2,3,3a,4,6,7,8,9‐octahydro‐1H‐pyrrolo[3,4‐c]pyrano[6,5‐b]cyclohexan‐9‐one
暂无分享,去创建一个
The title compound, C22H29NO4S, crystallizes with three independent molecules, A, B and C, in the asymmetric unit. Each of the three independent molecules adopts a folded conformation, with the phenylsulfonyl group lying over the pyranocyclohexanone ring system, and with the pyrrolidine and dihydropyran rings cis-fused. In all three molecules, the pyrrolidine ring has a twist conformation and the dihydropyran ring is in a half-chair conformation. The cyclohexenone rings adopt envelope conformations, with the flap atom puckered towards the phenylsulfonyl group in molecule A, and away from that group in molecules B and C, resulting in a different overall conformation for molecule A compared to B and C. In all molecules, the tosyl group is equatorially attached to the pyrrolidine ring. In the crystal structure, the molecules are linked into a three-dimensional framework by C—H⋯O hydrogen bonds.
[1] M. Millan,et al. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626. , 2000, The Journal of pharmacology and experimental therapeutics.
[2] D. Cremer,et al. General definition of ring puckering coordinates , 1975 .